Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachelle W Johnson

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Clinical & Experimental Metastasis|November 1, 2014
Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancerRachelle W Johnson, Alyssa R Merkel, Jonathan M Page, et al.
Journal of Bone Oncology|March 9, 2026
Abaloparatide and paclitaxel combination therapy Improves bone volume and tumor burden in Bone-Metastatic breast cancerJade S Miller, Jeremy F Kane, Patricia A Ward, et al.
JCI Insight|September 8, 2017
Prevention of breast cancer skeletal metastases with parathyroid hormoneSrilatha Swami, Joshua Johnson, Lance A Bettinson, et al.
The Journal of Endocrinology|September 18, 2014
gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiationTherese Standal, Rachelle W Johnson, Narelle E McGregor, et al.
Bone|August 11, 2015
Glycoprotein130 (Gp130)/interleukin-6 (IL-6) signalling in osteoclasts promotes bone formation in periosteal and trabecular boneRachelle W Johnson, Narelle E McGregor, Holly J Brennan, et al.
JBMR Plus|June 30, 2025
Abaloparatide increases bone mass without affecting growth of bone-disseminated cancer cellsJeremy F Kane, Gwenyth J Joseph, Lawrence A Vecchi, et al.
Bone|February 4, 2014
Co-registration of multi-modality imaging allows for comprehensive analysis of tumor-induced bone diseaseErin H Seeley, Kevin J Wilson, Thomas E Yankeelov, et al.
Communications Biology|September 24, 2021
Hypoxia inducible factor signaling in breast tumors controls spontaneous tumor dissemination in a site-specific mannerVera M Todd, Lawrence A Vecchi, Miranda E Clements, et al.
Frontiers in Endocrinology|June 6, 2018
Parathyroid Hormone-Related Protein Negatively Regulates Tumor Cell Dormancy Genes in a PTHR1/Cyclic AMP-Independent MannerRachelle W Johnson, Yao Sun, Patricia W M Ho, et al.
Endocrinology|April 9, 2016
Prepubertal Di-n-Butyl Phthalate Exposure Alters Sertoli and Leydig Cell Function and Lowers Bone Density in Adult Male MiceAmanda Bielanowicz, Rachelle W Johnson, Hoey Goh, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Clinical & Experimental Metastasis|November 1, 2014
Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancerRachelle W Johnson, Alyssa R Merkel, Jonathan M Page, et al.
Journal of Bone Oncology|March 9, 2026
Abaloparatide and paclitaxel combination therapy Improves bone volume and tumor burden in Bone-Metastatic breast cancerJade S Miller, Jeremy F Kane, Patricia A Ward, et al.
JCI Insight|September 8, 2017
Prevention of breast cancer skeletal metastases with parathyroid hormoneSrilatha Swami, Joshua Johnson, Lance A Bettinson, et al.
The Journal of Endocrinology|September 18, 2014
gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiationTherese Standal, Rachelle W Johnson, Narelle E McGregor, et al.
Bone|August 11, 2015
Glycoprotein130 (Gp130)/interleukin-6 (IL-6) signalling in osteoclasts promotes bone formation in periosteal and trabecular boneRachelle W Johnson, Narelle E McGregor, Holly J Brennan, et al.
JBMR Plus|June 30, 2025
Abaloparatide increases bone mass without affecting growth of bone-disseminated cancer cellsJeremy F Kane, Gwenyth J Joseph, Lawrence A Vecchi, et al.
Bone|February 4, 2014
Co-registration of multi-modality imaging allows for comprehensive analysis of tumor-induced bone diseaseErin H Seeley, Kevin J Wilson, Thomas E Yankeelov, et al.
Communications Biology|September 24, 2021
Hypoxia inducible factor signaling in breast tumors controls spontaneous tumor dissemination in a site-specific mannerVera M Todd, Lawrence A Vecchi, Miranda E Clements, et al.
Frontiers in Endocrinology|June 6, 2018
Parathyroid Hormone-Related Protein Negatively Regulates Tumor Cell Dormancy Genes in a PTHR1/Cyclic AMP-Independent MannerRachelle W Johnson, Yao Sun, Patricia W M Ho, et al.
Endocrinology|April 9, 2016
Prepubertal Di-n-Butyl Phthalate Exposure Alters Sertoli and Leydig Cell Function and Lowers Bone Density in Adult Male MiceAmanda Bielanowicz, Rachelle W Johnson, Hoey Goh, et al.
Pageof 6